News
Catch up on our latest updates
Innovation is one of the pillars of Eclipsebio’s culture, and our team of RNA experts is always developing new technologies and solutions. Learn more about our latest breakthroughs below.
Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
Eclipsebio's eCOMPASS platform combines AI-optimized design and sequencing-based analytics to produce successful RNA therapeutics efficiently.
2026 mRNA Innovators Award Call for Applications
The mRNA Innovators Award offers matching funds to design and validate a therapeutic of interest using Eclipsebio's design models and characterization methods.
Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics
Originally posted on Business Wire SAN DIEGO, January 26, 2026 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics for RNA therapeutics, today announced the acquisition of Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics. The acquisition accelerates Eclipsebio’s strategy to deliver an integrated, data-first platform to support RNA […]
Eclipsebio Launches eVERSE™, a First-of-Its-Kind Comprehensive Portfolio of RNA-Focused Datasets for AI Model Success
Eclipse Bioinnovations, Inc. (Eclipsebio), the leading partner for RNA-based and RNA-targeting therapeutic development, today announced the launch of its eVERSE™ portfolio of AI-ready datasets. eVERSE is a first-in-class collection of datasets generated from all key aspects of RNA biology that inform therapeutic development from target discovery to drug design.
2025 Data Catalyst Award Announcement
To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.
Decoding Microproteins Across Evolution and Disease
Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.